ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,964
Screening encounters
3,367
Diagnostic referrals
643
Outstanding pathways
241

Screening pathway

  1. Screening3,367Encounters
  2. Positive finding1,159Documented findings
  3. Referral643Diagnostic referrals
  4. Follow-up758Diagnostic visits
  5. Outcome402Resolved pathways

Stage totals use different units. Pending pathways: 241. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0160 · EXP-0160Synthetic · Site B

Full participant history through 2026-06-15, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-10-26
  4. · Diagnostic referral · EXP-0160-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Screened participants

2964 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0620 · Expanded synthetic participant 0620Site C — Rural Outreach Programme
EXP-0621 · Expanded synthetic participant 0621Site D — Community Engagement Programme
EXP-0626 · Expanded synthetic participant 0626Site B — Peri-Urban Access Programme
EXP-0628 · Expanded synthetic participant 0628Site E — Resource-Constrained Navigation Programme
EXP-0632 · Expanded synthetic participant 0632Site E — Resource-Constrained Navigation Programme
EXP-0633 · Expanded synthetic participant 0633Site E — Resource-Constrained Navigation Programme
EXP-0634 · Expanded synthetic participant 0634Site B — Peri-Urban Access Programme
EXP-0635 · Expanded synthetic participant 0635Site A — Urban Referral Hub
EXP-0640 · Expanded synthetic participant 0640Site B — Peri-Urban Access Programme
EXP-0641 · Expanded synthetic participant 0641Site E — Resource-Constrained Navigation Programme
EXP-0642 · Expanded synthetic participant 0642Site E — Resource-Constrained Navigation Programme
EXP-0643 · Expanded synthetic participant 0643Site C — Rural Outreach Programme
EXP-0644 · Expanded synthetic participant 0644Site E — Resource-Constrained Navigation Programme
EXP-0645 · Expanded synthetic participant 0645Site A — Urban Referral Hub
EXP-0646 · Expanded synthetic participant 0646Site B — Peri-Urban Access Programme
EXP-0647 · Expanded synthetic participant 0647Site A — Urban Referral Hub
EXP-0648 · Expanded synthetic participant 0648Site C — Rural Outreach Programme
EXP-0649 · Expanded synthetic participant 0649Site A — Urban Referral Hub
EXP-0652 · Expanded synthetic participant 0652Site A — Urban Referral Hub
EXP-0654 · Expanded synthetic participant 0654Site D — Community Engagement Programme
EXP-0656 · Expanded synthetic participant 0656Site A — Urban Referral Hub
EXP-0657 · Expanded synthetic participant 0657Site D — Community Engagement Programme
EXP-0658 · Expanded synthetic participant 0658Site C — Rural Outreach Programme
EXP-0659 · Expanded synthetic participant 0659Site A — Urban Referral Hub
EXP-0660 · Expanded synthetic participant 0660Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1352
HPV DNA
1519
Cytology
496

Navigation activity

Barrier documented
549
Contact attempt
945
Navigation intervention
237
Diagnostic booking
796
Diagnostic visit
758

Documented barriers

Contact difficulty
181
Transport difficulty
169
Appointment coordination
199

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.